According to them, the vaccine can safely and effectively train the immune system to recognise and fight cancer-driving ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back.

A new 'off-the-shelf' vaccine with the catchy name ELI-002 2P offers fresh hope for individuals affected by these deadly ...

Dr. Zev Wainberg of UCLA recently spoke with CURE about trial results concerning the cancer vaccine ELI-002 2P.

Response Pharmaceuticals’ drug has helped reduce the amount of weight a patient regains after treatment with glucagon-like ...

The mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key immune ...

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

Response Pharmaceuticals has shared phase 2 data in post-GLP-1 patients, linking its ex-Sanofi asset to reductions in ...

A new pancreatic cancer vaccine has appeared to slow disease progression and increase survival for patients in an early trial ...

Experimental vaccines shrouded in controversy and targeted by health secretary Robert F Kennedy Jr may protect against one of ...